First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer

BACKGROUND: Therapeutic options are limited for advanced, metastatic biliary tract cancer. The pivotal NAPOLI-1 trial demonstrated the superior clinical benefit of nanoliposomal irinotecan (Nal-IRI) in gemcitabine-pretreated patients with metastatic pancreatic ductal adenocarcinoma; however, the ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghizadeh, Hossein, Unseld, Matthias, Schmiderer, Andreas, Djanani, Angela, Wilthoner, Klaus, Buchinger, Dieter, Prager, Gerald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338813/
https://www.ncbi.nlm.nih.gov/pubmed/32556829
http://dx.doi.org/10.1007/s00280-020-04094-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338813/
https://www.ncbi.nlm.nih.gov/pubmed/32556829
http://dx.doi.org/10.1007/s00280-020-04094-0

Ejemplares similares